Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | CASP1 | P29466 | 1/20 | 0.31 |
| ▸ | CASP7 | P55210 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | SIRT2 | Q8IXJ6 | 1/20 | 0.31 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24450742 | 0.94 | TSHR (0.32) | KDM4EALDH1A1MAPTHPGDALOX15 | |
| SCHEMBL22257555 | 0.88 | KDM4E (0.32) | KDM4EALDH1A1MAPTHPGDALOX15 | |
| SCHEMBL24450732 | 0.87 | TERT (0.30) | — | |
| SCHEMBL24450731 | 0.87 | PRKDC (0.32) | KDM4EALDH1A1MAPTHPGDTSHR | |
| SCHEMBL24702691 | 0.87 | TERT (0.32) | KDM4EALDH1A1MAPTHPGDTSHR | |
| SCHEMBL22257416 | 0.86 | TSHR (0.34) | KDM4EALDH1A1MAPTHPGDALOX15 | |
| SCHEMBL24450682 | 0.85 | TSHR (0.34) | ALDH1A1HPGDALOX15TSHRCASP1 | |
| SCHEMBL22257554 | 0.85 | SIRT2 (0.36) | KDM4EALDH1A1MAPTHPGDALOX15 | |
| SCHEMBL22257418 | 0.85 | SIRT2 (0.36) | KDM4EALDH1A1MAPTHPGDALOX15 | |
| SCHEMBL24363350 | 0.85 | KDM4E (0.35) | KDM4EALDH1A1MAPTHPGDALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220162210-A1 | ORGANIC ELECTROLUMINESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME | DUPONT SPECIALTY MATERIALS KOREA LTD (KR) | 2022-05-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220162210-A1 | ORGANIC ELECTROLUMINESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME | OR10J3, CTCF, LAGE3 | KDM4E 2018/4885ALDH1A1 1476/4885MAPT 1112/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.